St. Theresien-Krankenhaus Nürnberg

Cardiovascular Safety of GnRH Agonist-Based Androgen Deprivation Therapy in a Real-World Setting: Results from a Prospective Cohort Study (LEAN) (2025) Schmitz-Dräger BJ, Bismarck E, Ebert T, Starlinger R, Dienes K, Ottillinger B, Goebell P, et al. Journal article Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study (2024) Schmitz-Dräger C, Goebell P, Paxinos E, Bismarck E, Chen J, Balakrishnan P, Bates M, et al. Journal article Perinatal Outcome in Pregnant Women With Isolated Oligohydramnios Diagnosed With the Single Deepest Pocket Method (2024) Dammer U, Pretscher J, Weiss C, Schneider M, Faschingbauer F, Beckmann M, Kehl S Journal article Trial of labor after caesarean section in low risk pregnancies: is it risky? (2024) Kehl S, Düster H, Weiss C, Bader S, Schneider M, Beckmann M, Dammer U, Pretscher J Journal article Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial (2024) Grimm MO, Schostak M, Grün CB, Loidl W, Pichler M, Zimmermann U, Schmitz-Dräger B, et al. Journal article Simulation of the effects of molecular urine markers in follow-up of patients with high-risk non-muscle invasive bladder cancer (2024) Benderska-Söder N, Ecke T, Kleinlein L, Roghmann F, Bismarck E, van Rhijn BWG, Stenzl A, et al. Journal article, Review article Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-muscle-Invasive Bladder Cancer (2023) Ecke TH, Benderska-Söder N, Bismarck E, van Rhijn BWG, Todenhöfer T, Schmitz-Dräger BJ Book chapter / Article in edited volumes Tailored immunotherapy approach with nivolumab with or without ipilimumab in patients with advanced transitional cell carcinoma after platinum-based chemotherapy (TITAN-TCC): a multicentre, single-arm, phase 2 trial (2023) Grimm MO, Grün CB, Niegisch G, Pichler M, Roghmann F, Schmitz-Dräger B, Baretton G, et al. Journal article Tailored Immunotherapy Approach With Nivolumab in Advanced Transitional Cell Carcinoma (2022) Grimm MO, Schmitz-Dräger BJ, Zimmermann U, Grün CB, Baretton GB, Schmitz M, Foller S, et al. Journal article Individualized Wound Closure - Mechanical Properties of Suture Materials (2022) Polykandriotis E, Daenicke J, Bolat A, Grüner J, Schubert DW, Horch RE Journal article